The INTERHEART [67] and AFCAPS/TexCAPS [68] investigations have shown a clear linear link between the ApoB/ApoA1 ratio and CAD risk, establishing it as the most reliable predictor of CAD risk. This evidence concerns the gene APOB and coronary artery disorder.